- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Terrill Jordan Discusses the Process of Customizing an EMR to Adapt to OCM
In order to adapt to the Oncology Care Model (OCM), Regional Cancer Care Associates had to undergo the process of adjusting and customizing its electronic medical records, explained CEO Terrill Jordan.
In order to adapt to the Oncology Care Model (OCM), Regional Cancer Care Associates had to undergo the process of adjusting and customizing its electronic medical records, explained CEO Terrill Jordan.
Transcript
Did you have to upgrade your electronic health records to adapt to OCM requirements, and what was that process like?
We did and it wasn’t so much as upgrade as we had to customize a lot of the workflows. What we found was that the EMRs weren’t developed with value based in mind while there were a lot of structure fields, the structure fields weren’t in a place to be used within the workflow. So what we had to do was customize little drop down boxes, we had to customize different fields so our clinicians could put structured data in along with their daily exercise of seeing patients. That was the main change with the EMR.
In terms of some of the other software we had, we found that a lot of the other software wasn’t meant to interface with the EMR—and the EMR being so critical to our understanding of the clinical, marrying that up with the claims data, marrying that up with our payment data—we found that the interface was also an issue.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More
